Aug 7 (Reuters) - Aptose Biosciences Inc APS.TO :
* APTOSE REPORTS RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2018
* APTOSE BIOSCIENCES INC - QTRLY LOSS PER SHARE $0.30
* APTOSE BIOSCIENCES INC - INCREASE IN QTRLY NET LOSS WAS PRIMARILY DRIVEN BY PAYMENT OF ONE-TIME LICENSE FEES IN AMOUNT $5.0 MILLION TO CRYSTALGENOMICS
* APTOSE BIOSCIENCES - EXCLUDING ONE-TIME LICENSE FEES PAYMENTS, NET LOSS FOR THREE MONTHS ENDED JUNE 30, 2018 WOULD HAVE BEEN $5.3 MILLION AND $0.16/SHARE